Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome-Single Centre Observational Study in the United Kingdom

Semin Thromb Hemost. 2023 Jul;49(5):553-557. doi: 10.1055/s-0042-1757633. Epub 2022 Nov 1.

Authors

Hithin Noble^#¹, Christina Crossette-Thambiah^#^{1

2}, Zain Odho³, Nilanthi Karawitage¹, Karen Logan¹, Charis Pericleous⁴, Mike Laffan^{1

2}, Deepa R J Arachchillage^{1

2}

Affiliations

¹ Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.
² Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
³ Department of Laboratory medicine, Royal Brompton Hospital, London, United Kingdom.
⁴ National Heart and Lung Institute, Imperial College London, London, United Kingdom.

^# Contributed equally.

PMID: 36318961
DOI: 10.1055/s-0042-1757633

No abstract available

Publication types

Observational Study

MeSH terms

Antiphospholipid Syndrome*
Clinical Relevance
Humans
Phosphatidylserines
Prothrombin
United Kingdom

Substances

Prothrombin
Phosphatidylserines

Grants and funding